K2 HEMI TOE IMPLANT SYSTEM (FORMERLY ZOBEL GREAT TOE IMPLANT SYSTEM)— 510(k) K023770

Name: FDA 510(k) clearance K023770
Creator: U.S. Food and Drug Administration
Published: 2002-12-12

Substantially Equivalent

Kinetikos Medical, Inc.

FDA 510(k) clearance K023770 for K2 HEMI TOE IMPLANT SYSTEM (FORMERLY ZOBEL GREAT TOE IMPLANT SYSTEM), Substantially Equivalent on 2002-12-12. Applicant: Kinetikos Medical, Inc.. Device class: 2.

Clearance details

Applicant: Kinetikos Medical, Inc.
Product code: Code KWD
Device class: Class 2
Regulation: 21 CFR 888.3730
Advisory panel: Orthopedic
Date received: 2002-11-12
Decision date: 2002-12-12
Decision: Substantially Equivalent
Clearance type: Special
Location: San Diego, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KWD

view all

K250074 — HYALEX® MTP Hemiarthroplasty Implant2026-04-03
K240268 — Accu-Joint Hemi Implant2024-02-29
K221220 — Montross Extremity Medical Hemi Implant System2023-04-19
K222964 — BioPoly Lesser Toe Hemiarthroplasty Implant2022-11-22
K201393 — restor3d MTP Implant2022-05-25

More clearances from Kinetikos Medical, Inc.

view all

K061749 — ECLIPSE TOTAL ANKLE IMPLANT2006-11-22
K061465 — KMI CEMENT RESTRICTOR IMPLANT2006-10-05
K051611 — MBARESORB IMPLANT2005-09-06
K041461 — KMI DISTAL VOLAR RADIUS PLATE SYSTEM2004-08-16
K032806 — KATALYST RADIAL HEAD IMPLANT2004-04-16

Adverse events under product code KWD

product code KWD

Injury: 164
Total: 164

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.